These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5977936)

  • 1. [Methyldopa. Blood pressure lowering effect of the d,1- and the 1-form].
    Krogsgaard AR
    Ugeskr Laeger; 1966 Dec; 128(52):1560-3. PubMed ID: 5977936
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the blood pressure lowering effect of cyclazenin and a cyclazenin-alpha-methyldopa combination].
    Seige K; Preuss EG; Mörl H; Köhler I; Lantzsch W
    Med Welt; 1969 Mar; 10():520-6. PubMed ID: 5772239
    [No Abstract]   [Full Text] [Related]  

  • 3. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
    Fitz AE; Saunders E
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S85-91. PubMed ID: 6172671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of phonocardiographic and apex cardiographic abnormalities in hypertensive disease and their responsiveness to alpha-methyldopa.
    Strausz I; Kékes E; Horányi P; Barcsák J
    Ther Hung; 1973; 21(3-4):97-100. PubMed ID: 4806428
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simplified treatment of hypertension using Tadip].
    Kumpmann U
    Med Welt; 1968 Nov; 46():2553-6. PubMed ID: 5731380
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
    Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
    G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in renal function and electrolyte transport after acute decrease of blood pressure induced by a decarboxylase inhibitor (alpha-methyldopa)].
    Koçak N; Kalkay N; Ozdoğan E
    Turk Tip Cemiy Mecm; 1967; 33(11):671-80. PubMed ID: 5598385
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term treatment of hypertension with methyldopa. I. Study objectives and design.
    Itskovitz HD; Menduke H
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S79-84. PubMed ID: 6172670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyldopa in hypertension.
    Omar JB; Agarwal SN; Parameshwaran T
    J Indian Med Assoc; 1968 Jun; 50(12):563-7. PubMed ID: 5708637
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methyldopa: study of the antihypertensive and renin-reducing effects at rest and after exercise].
    Sbissa AS; Sbissa LA; Thiesen AL; Zunino JN
    Arq Bras Cardiol; 1981 Sep; 37(3):213-7. PubMed ID: 7052027
    [No Abstract]   [Full Text] [Related]  

  • 17. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experiences with alpha-methyldopa in the therapy of arterial hypertension].
    Schimke K
    Med Klin; 1965 Sep; 60(38):1536-41. PubMed ID: 5861903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.